NCT03729752View on ClinicalTrials.gov

PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 31, 2026

Study Completion Date

December 1, 2026

Conditions
HIV-1-infection
Interventions
DRUG

[89]Zr-DFO-VRC-HIVMAB060-00-AB

Radiolabeled monoclonal antibody that targets the envelope protein of HIV-1.

Trial Locations (1)

94110

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

amfAR, The Foundation for AIDS Research

OTHER

lead

University of California, San Francisco

OTHER

NCT03729752 - PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) | Biotech Hunter | Biotech Hunter